A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Doxorubicin (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- 14 Dec 2019 Results evaluating the efficacy and safety of genexol- PM and doxorubicin combination in advanced Her-2 negative Breast cancer as first line treatment presented at the 42nd Annual San Antonio Breast Cancer Symposium
- 11 Feb 2013 New trial record